Dollar mired in US economic weakness and trade limbo
SINGAPORE: The dollar was headed for a weekly loss on Friday, undermined by signs of fragility in the US economy and as trade negotiations between Washington and its trading partners made little progress despite a looming deadline.
Key for markets will be the US nonfarm payrolls report later on Friday, which will draw greater scrutiny after a slew of weaker-than-expected economic data this week underscored the headwinds from President Donald Trump's tariffs.
Currencies were taken on a round trip overnight, with most surging against the dollar initially on optimism that Trump and Chinese leader Xi Jinping spoke in a more than one-hour-long call, before paring some of their gains.
The euro also got a further lift from the European Central Bank's (ECB) hawkish rhetoric following a widely expected rate cut, which sent the common currency to a 1-1/2-month high of US$1.1495 on Thursday.
It last traded 0.05 per cent higher at US$1.1449.
"We are inclined to treat Lagarde's hawkishness...with a degree of caution, albeit given this shift in tone, we no longer see our previous forecast for a 1.50 per cent terminal rate as the most likely outcome," said Nick Rees, head of macro research at Monex Europe.
He now expects just one more rate cut in September which will take the deposit rate to 1.75 per cent.
Most currency pairs were also little changed in the early Asian session on Friday, with sterling up just 0.1 per cent to US$1.3583 having scaled a more than three-year top in the previous session. It was set to rise 0.9 per cent for the week.
The yen fell 0.1 per cent to 143.74 per dollar.
Against a basket of currencies, the dollar was little changed at 98.72 after having hit a six-week low on Thursday, and was headed for a weekly loss of 0.7 per cent.
All eyes are now on Friday's jobs data to determine the next move in currencies.
Expectations are for nonfarm payrolls to have increased by 130,000 jobs last month, while the unemployment rate is forecast to hold steady at 4.2 per cent, with greater risks of a rise to 4.3 per cent.
"Within all the noise...the softness that we've seen in the data this week has probably been more responsible for rejuvenating the bearish US dollar narrative than anything else that's gone on," said Ray Attrill, head of FX research at National Australia Bank.
"We've always taken the view that once it becomes clear that the US economy is no longer exceptional, and that the policy actions that we've seen to date, together with the relative tightness of Fed policy, will start to show through particularly in a weakening labour market. Hence the importance of tonight's numbers."
Adding to headwinds for the dollar, investors remain worried about US trade negotiations and the lack of progress in hashing out deals ahead of an early July deadline.
The highly anticipated call between Trump and Xi also provided little clarity and the spotlight on it was quickly stolen by a public fallout between Trump and Elon Musk.
Elsewhere, the Australian dollar ticked up 0.06 per cent to US$0.6512, and was set for a 1.1 per cent weekly rise.
The New Zealand dollar rose 0.17 per cent to US$0.6048 and was also headed for a 1.1 per cent weekly gain.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
3 hours ago
- Malaysian Reserve
ZBIO Deadline: ZBIO Investors with Losses in Excess of $100K Have Opportunity to Lead Zenas BioPharma, Inc. Securities Lawsuit Filed by The Rosen Law Firm
NEW YORK, June 6, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and prospectus (collectively, the 'Registration Statement') issued in connection with Zenas BioPharma's September 2024 initial public offering ('IPO' or the 'Offering'), of the important June 16, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So What: If you purchased Zenas BioPharma securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Zenas BioPharma class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@ for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 16, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, the Registration Statement contained false and/or misleading statements and/or failed to disclose that: (1) Zenas BioPharma materially overstated the amount of time it would be able to fund its operations using existing cash and expected net proceeds from the IPO; and (2) as a result, defendants' public statements were materially false and misleading at all relevant times and negligently prepared. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Zenas BioPharma action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@ for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@
Free Malaysia Today
3 hours ago
- Free Malaysia Today
Trump says Fed should cut interest rate by a full point
The Federal Reserve kept rates at 4.25%-4.50% in May, signalling a possible pause while awaiting clarity on Donald Trump's tariffs. (Reuters pic) WASHINGTON : The US Federal Reserve should cut interest rates by a full percentage point, President Donald Trump said on Friday as he reiterated his view that Fed Chair Jerome Powell has been too slow to lower borrowing costs. 'Europe has had 10 rate cuts, we have had none. Despite (Powell), our Country is doing great. Go for a full point,' Trump wrote in a social media post. Central banks typically limit rate moves to quarter point changes. Trump said the Fed could always raise rates again if cuts led to inflation. The president has repeatedly berated Powell for not cutting rates as he desires. The two men met face-to-face for the first time last week, with Trump telling Powell he was making a 'mistake' by not lowering rates. The Fed in May left the policy rate in the 4.25%-4.50% range, where it has been since December, and policymakers have since signalled they may leave it there for another few months as they wait for more clarity on Trump's tariff policy.
The Star
3 hours ago
- The Star
Roundup: Europeans turn away from U.S. amid growing anti-American sentiment
LONDON, June 6 (Xinhua) -- While waiting in line outside Rome's iconic Gallery Borghese with his family, Polish tourist Antoni Furman shared why the United States is never on his holiday list. "Europe is much less crowded, and the U.S. tariffs on the European Union affect our pockets," he said. Furman represents a growing number of Europeans opting out of engaging with the United States. A wave of anti-American sentiment is sweeping across the continent, as U.S. policies strain the transatlantic relationship and influence everyday decisions - from travel choices to consumer behavior. Inbound travel to the U.S. is projected to decline by 8.7 percent in 2025, with the sharpest drops expected from Canada and Western Europe, according to Oxford Economics. Data from the U.S. National Travel and Tourism Office revealed that trips from overseas fell by 11.6 percent in March 2025 compared to the previous year. Visits from Western Europe alone plummeted 17.2 percent. Germany, Spain, and Ireland each saw declines exceeding 20 percent, while the United Kingdom and France recorded decreases of around 10 percent. Travel booking platform Omio reported a 16 percent increase in U.S. trip cancellations in the first quarter (Q1) year-on-year, with cancellation rates from the UK, Germany, and France nearing 40 percent. Tourism Economics, part of Oxford Economics, noted a 10 percent decline in European trip plans to the U.S. for the 2025 summer season. Oxford Economics pointed to several causes for the gloomy tourism outlook: trade tariffs targeting traditional allies, troubling media reports on border security, and controversial travel advisories. Adam Sacks, president of Tourism Economics, criticized the Trump administration's approach, noting that Trump's aggressive rhetoric toward the European Union (EU), Greenland, and Canada are all unforced errors, and have impacts on how people view the U.S. A British woman working in sports echoed this sentiment, saying, "I disagree with many of Trump's policies. The U.S. just doesn't seem like a positive place. I'd rather visit France - and I think most Brits complain about Trump's policies." Avoiding travel is just one of the many ways Europeans are rejecting American influence. From daily household goods to tech and media, European consumers are actively boycotting U.S. brands. In Denmark, a Facebook group titled "Boykot varer fra USA (Boycott goods from USA)" surged to 95,000 members by April. Similar initiatives emerged in Norway, Sweden, Germany, France, and Poland, urging consumers to favor European-made products. On Reddit, around 200,000 members of the BuyFromEU community share alternatives to American brands such as Netflix, McDonald's, and Apple - down to everyday items like socks, ketchup, and headphones. To support the movement, European developers have launched barcode-scanning apps to help consumers identify the country of origin for products. Many supermarkets now feature dedicated sections for European goods, with clear signage highlighting EU-made products. Goldman Sachs analysts warned that the U.S. could lose up to 90 billion U.S. dollars in revenue in 2025 due to declining tourism and mounting international boycotts. The resulting slowdown could modestly drag on the country's GDP, primarily through reduced foreign tourism. Trump has destroyed the reputation of the U.S., said Paul English, co-founder of travel website Kayak. He stressed that the reduction of travels to the U.S. is not only one more terrible blow to the country's economy, but also represents reputation damage that could take generations to repair.
